Colin Pharmaceutical: Brexpiprazole Oral Dissolving Film and Two Other Products Approved for Drug Registration

MetaMuskRat · 2026-03-22T01:57:25+00:00

Coren Pharmaceutical recently received approval from the National Medical Products Administration. Its independently developed "Brexpiprazole Oral Soluble Film" and "Injectable Aripiprazole" have been officially registered. The former has advantages such as convenient administration and can effectively address the risk of medication non-compliance in patients with schizophrenia.

MetaMuskRat

2026-03-22 01:57:25

Abstract generation in progress

People’s Financial News, March 20 — Kolon Pharmaceutical (002422) announced on March 20 that its chemical drug “Brexpiprazole Orally Disintegrating Film” has recently received drug registration approval from the National Medical Products Administration. This drug is an independently developed new improved medication by the company. Compared to tablets, it offers advantages such as easy administration without water, dissolving within seconds in the oral cavity, and easy swallowing, effectively addressing the risk of concealed medication for patients with schizophrenia. On the same day, the subsidiary Hunan Kolon Pharmaceutical Co., Ltd. announced that its chemical drug “Aripiprazole Injection” has also recently received drug registration approval from the National Medical Products Administration. This medication is used for adult schizophrenia.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes